TP53 and non-small cell lung carcinoma: SCLC is also associated with a high mutation burden, including the inactivation of tumor suppressor genes, such as retinoblastoma 1 (RB1), and frequent mutations in tumor protein 53 (TP53) [10] compared to patients with NSCLC [8].